Prudential Financial Inc. trimmed its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 17.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,056 shares of the company’s stock after selling 226 shares during the quarter. Prudential Financial Inc.’s holdings in Chemed were worth $559,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. CIBC Asset Management Inc lifted its stake in shares of Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after buying an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC lifted its position in Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after acquiring an additional 22 shares in the last quarter. EP Wealth Advisors LLC boosted its stake in Chemed by 1.9% during the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after purchasing an additional 25 shares during the last quarter. Independent Advisor Alliance increased its holdings in Chemed by 1.1% during the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock worth $1,207,000 after purchasing an additional 25 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Chemed by 7.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company’s stock worth $264,000 after purchasing an additional 33 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Chemed
In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 3.32% of the company’s stock.
Chemed Stock Down 0.6 %
Chemed Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.35%. Chemed’s dividend payout ratio is currently 10.05%.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the company. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada upped their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.
Check Out Our Latest Stock Analysis on CHE
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories
- Five stocks we like better than Chemed
- Business Services Stocks Investing
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- How to Effectively Use the MarketBeat Ratings Screener
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- What is the NASDAQ Stock Exchange?
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.